Bibliografisk note

Funding Information:
The Copenhagen City Heart Study was funded by the Danish Heart Foundation. The echocardiographic substudy was funded by the Lundbeck Foundation. F.J.O. was funded by grants from the Danish Heart Foundation (no. 18-R125-A8534-22083), Fru Asta Florida Boldings Mindelegat, Kong Christian den Tiendes fond, and Copenhagen University Hospital—Herlev and Gentofte Hospital. T.B.-S. was supported by the Fondbørsvekselerer Henry Hansen og Hustrus Hovedlegat, the Lundbeck Foundation, and the Novo Nordisk Foundation. The funding organizations did not have any involvement in study design, conduct, or manuscript preparation. Conflicts of Interest: T.B.-S. is a Steering Committee member of the Amgen-financed GALACTIC-HF trial and the Boston Scientific–financed LUX-Dx TRENDS trial; is on the Advisory Board of Sanofi Pasteur and Amgen; received a speaker honorarium from Novartis and Sanofi Pasteur; and received research grants from GE Healthcare and Sanofi Pasteur. None of these organizations had any involvement in the study.

Funding Information:
The Copenhagen City Heart Study was funded by the Danish Heart Foundation . The echocardiographic substudy was funded by the Lundbeck Foundation . F.J.O. was funded by grants from the Danish Heart Foundation (no. 18-R125-A8534-22083 ), Fru Asta Florida Boldings Mindelegat , Kong Christian den Tiendes fond , and Copenhagen University Hospital — Herlev and Gentofte Hospital . T.B.-S. was supported by the Fondbørsvekselerer Henry Hansen og Hustrus Hovedlegat , the Lundbeck Foundation , and the Novo Nordisk Foundation . The funding organizations did not have any involvement in study design, conduct, or manuscript preparation.